Press release from Companies
Publicerat: 2019-05-31 09:00:00
FluoGuide A/S ("FluoGuide") today announces its results for the period 01/Jan/2019 – 31/Mar/2019. The report is available on https://fluoguide.com/investor/filings-reports/.
Morten Albrechtsen, CEO of FluoGuide, comments:
“Not even a month has passed since FluoGuide’s very successful IPO and listing at Spotlight Stock Market and I am very pleased that we are now more than 1,000 shareholders working together to transform cancer surgery by lighting up the cancer for the benefit of patients and society in general. We have initiated the critical development activities needed for announcing the first clinical result for FG001 in second half of 2020 as planned.”
First quarter 2019 (January – March)
*) Result per share: Operating result divided by the average number of shares during the period. Total number of shares as of 31 March 2019, amounted to 4,000,000 (105,500). Average number of shares during Q1 2019 amounted to 4,733,333 (105,500). Please observe that the company has conducted a capital raise in April 2019 and that an additional 3,224,274 shares have been issued after the period.
**) Solidity:Equity divided by total capital.
Amount within brackets corresponds to comparable period in the previous year.
Highlights during Q1
Highlights after Q1
Morten Albrechtsen, CEO
M: +45 24 25 62 66
ma@fluoguide.com
FluoGuide A/S
Ole Maaløes Vej 3
DK-2200 Copenhagen N
Denmark
www.fluoguide.com